NASDAQ:CBUS Cibus (CBUS) Stock Price, News & Analysis → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free CBUS Stock Alerts $15.84 +0.30 (+1.93%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share Today's Range$15.50▼$16.0350-Day Range$14.90▼$22.8252-Week Range$8.90▼$38.85Volume35,000 shsAverage Volume62,142 shsMarket Capitalization$342.46 millionP/E RatioN/ADividend YieldN/APrice Target$25.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Cibus alerts: Email Address Cibus MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside57.8% Upside$25.00 Price TargetShort InterestBearish2.71% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.99) to ($2.26) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.32 out of 5 starsConsumer Staples Sector116th out of 131 stocksAgricultural Chemicals Industry9th out of 9 stocks 3.5 Analyst's Opinion Consensus RatingCibus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageCibus has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted2.71% of the float of Cibus has been sold short.Short Interest Ratio / Days to CoverCibus has a short interest ratio ("days to cover") of 6.Change versus previous monthShort interest in Cibus has recently increased by 0.21%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldCibus does not currently pay a dividend.Dividend GrowthCibus does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CBUS. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Cibus this week, compared to 1 article on an average week.MarketBeat Follows5 people have added Cibus to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cibus insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.40% of the stock of Cibus is held by insiders.Percentage Held by InstitutionsOnly 33.81% of the stock of Cibus is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Cibus are expected to grow in the coming year, from ($2.99) to ($2.26) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cibus is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cibus is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCibus has a P/B Ratio of 0.90. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. About Cibus Stock (NASDAQ:CBUS)Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.Read More CBUS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CBUS Stock News HeadlinesApril 25, 2024 | globenewswire.comCibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference CallMarch 23, 2024 | finance.yahoo.comCibus Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsApril 29, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.March 22, 2024 | markets.businessinsider.comCibus’s Market Potential and Advancements Justify Buy RatingMarch 22, 2024 | insidermonkey.comCibus, Inc. (NASDAQ:CBUS) Q4 2023 Earnings Call TranscriptMarch 21, 2024 | investorplace.comCBUS Stock Earnings: Cibus Beats EPS, Beats Revenue for Q4 2023March 21, 2024 | stockhouse.comCibus Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024March 21, 2024 | finance.yahoo.comCibus Inc (CBUS) Reports Q4 Financial Results and Business DevelopmentsApril 29, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.March 21, 2024 | globenewswire.comCibus Reports Fourth Quarter Financial Results and Provides Business UpdateMarch 19, 2024 | finance.yahoo.comCibus Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2024March 17, 2024 | finance.yahoo.comCBUS May 2024 30.000 callMarch 17, 2024 | finance.yahoo.comCBUS Sep 2024 12.500 putMarch 13, 2024 | globenewswire.comCibus to Participate in the 36th Annual Roth ConferenceMarch 7, 2024 | finance.yahoo.comCibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference CallFebruary 26, 2024 | globenewswire.comCibus and Loveland Products Collaborate to Develop and Sell Rice Traits in the USFebruary 25, 2024 | seekingalpha.comEU Greenlights Cibus To Enter Its Massive MarketFebruary 7, 2024 | markets.businessinsider.comEuropean Parliament Votes to Support Proposal for the Regulation of New Genomic TechniquesJanuary 25, 2024 | markets.businessinsider.comEuropean Parliament’s Environment Committee Votes to Support New Proposal for the Regulation of New Genomic TechniquesJanuary 17, 2024 | finance.yahoo.comCibus 2023 Field Trial Results Move Developed Traits Closer to Product SalesJanuary 12, 2024 | seekingalpha.comCibus: Expanding Opportunities And Growing Accessible MarketJanuary 10, 2024 | msn.comCibus rises after it successfully regenerates wheat plant from single cellsJanuary 9, 2024 | finance.yahoo.comCibus Announces Major Breakthrough in Wheat Regeneration from Single CellsJanuary 4, 2024 | finance.yahoo.comCibus Enters into a Latin America Collaboration Agreement with Interoc to deliver rice growers an innovative rice weed control systemJanuary 1, 2024 | benzinga.comCibus Stock (NASDAQ:CBUS), Short Interest ReportDecember 20, 2023 | nasdaq.comInsiders Pour Millions Into These 3 Buy-Rated Stocks — Here’s Why You Might Want to Ride Their CoattailsDecember 16, 2023 | finance.yahoo.comCo-Founder of Cibus Picks Up 23% More StockSee More Headlines Receive CBUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cibus and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/21/2024Today4/29/2024Next Earnings (Confirmed)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Agricultural chemicals Sub-IndustryN/A Current SymbolNASDAQ:CBUS CUSIPN/A CIK1705843 Webwww.calyxt.com Phone(858) 450-0008FaxN/AEmployees183Year FoundedN/APrice Target and Rating Average Stock Price Target$25.00 High Stock Price Target$25.00 Low Stock Price Target$25.00 Potential Upside/Downside+57.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($22.68) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-267,640,000.00 Net Margins-14,729.06% Pretax Margin-18,582.44% Return on Equity-22.70% Return on Assets-12.98% Debt Debt-to-Equity RatioN/A Current Ratio1.65 Quick Ratio1.65 Sales & Book Value Annual Sales$1.82 million Price / Sales188.17 Cash Flow$11.00 per share Price / Cash Flow1.44 Book Value$17.57 per share Price / Book0.90Miscellaneous Outstanding Shares21,620,000Free Float20,672,000Market Cap$342.46 million OptionableOptionable Beta1.92 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Rory Balfour Riggs M.B.A. (Age 71)Co-Founder, CEO & Chairman Dr. Peter Beetham B.Sc. (Age 61)Ph.D., Co-Founder, President, COO & Director Dr. Greg Gocal Ph.D. (Age 55)Co-Founder, Chief Scientific Officer & Executive VP Dr. Wade Hampton King (Age 66)Chief Financial Officer Mr. Steve BerrethGeneral Counsel & Corporate SecretaryMs. Rosa Cheuk Kim J.D.Senior Vice President of LegalDr. James Radtke Ph.D.Senior Vice President of Product DevelopmentMr. Tony MoranSenior Vice President of International DevelopmentNorm SissonsSenior Vice President of Seed & TraitsMs. Noel Sauer Ph.D.Senior Vice President of ResearchMore ExecutivesKey CompetitorsAmerican VanguardNYSE:AVDMarrone Bio InnovationsNASDAQ:MBIILifeVantageNASDAQ:LFVNChina Green AgricultureNYSE:CGANatural Alternatives InternationalNASDAQ:NAIIView All CompetitorsInsiders & InstitutionsGlenview Capital Management LLCSold 3,498 shares on 2/15/2024Ownership: 0.697%Gladius Capital Management LPBought 2,861 shares on 2/7/2024Ownership: 0.017%Rory B RiggsBought 517,107 shares on 12/12/2023Total: $5.47 M ($10.58/share)View All Insider TransactionsView All Institutional Transactions CBUS Stock Analysis - Frequently Asked Questions Should I buy or sell Cibus stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cibus in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CBUS shares. View CBUS analyst ratings or view top-rated stocks. What is Cibus' stock price target for 2024? 1 equities research analysts have issued 1 year target prices for Cibus' shares. Their CBUS share price targets range from $25.00 to $25.00. On average, they anticipate the company's stock price to reach $25.00 in the next year. This suggests a possible upside of 57.8% from the stock's current price. View analysts price targets for CBUS or view top-rated stocks among Wall Street analysts. How have CBUS shares performed in 2024? Cibus' stock was trading at $19.64 at the start of the year. Since then, CBUS stock has decreased by 19.3% and is now trading at $15.84. View the best growth stocks for 2024 here. When is Cibus' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our CBUS earnings forecast. How can I listen to Cibus' earnings call? Cibus will be holding an earnings conference call on Thursday, May 9th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13745788". How were Cibus' earnings last quarter? Cibus, Inc. (NASDAQ:CBUS) announced its quarterly earnings data on Thursday, March, 21st. The company reported ($1.16) EPS for the quarter, missing the consensus estimate of ($1.12) by $0.04. The firm had revenue of $1.10 million for the quarter, compared to the consensus estimate of $0.27 million. Cibus had a negative trailing twelve-month return on equity of 22.70% and a negative net margin of 14,729.06%. When did Cibus IPO? Cibus (CBUS) raised $100 million in an initial public offering on Thursday, February 14th 2019. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Piper Jaffray served as the underwriters for the IPO. How do I buy shares of Cibus? Shares of CBUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CBUS) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cibus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
